CoChat

Molecular polymorphism of Aβ in Alzheimer's disease

Open access
LeVine, Harry, Walker, Lary C. · 2010 · Neurobiology of Aging
Cited by 52

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease is defined pathologically by the presence of senile plaques, which consist primarily of extracellular aggregates of fibrillar Abeta peptide, and neurofibrillary tangles, which are abnormal, intracellular bundles of fibrillar tau protein. The advent of amyloid binding agents as diagnostic imaging probes for Alzheimer's disease (AD) has made it imperative to understand at a molecular and disease level what these ligands are reporting. In addition to improving the accuracy of diagnosis, we argue that these selective ligands can serve as probes for molecular polymorphisms that may govern the pathogenicity of abnormal protein aggregates.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2008.05.026

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 41

  1. Aguzzi, 2007, Insights into prion strains and neurotoxicity, Nat. Rev. Mol. Cell. Biol., 8, 552, 10.1038/nrm2204 · DOI · Paper page
  2. Aslund, 2007, Studies of luminescent conjugated polythiophene derivatives: enhanced spectral discrimination of protein conformational states, Bioconjug. Chem., 18, 1860, 10.1021/bc700180g · doi:10.1021/bc700180g
  3. Attems, 2004, Amyloid beta peptide 1–42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology, Acta Neuropathol. (Berl.), 107, 283, 10.1007/s00401-004-0822-6 · DOI
  4. Chandra, 2006, Design, synthesis, and structure-activity relationship of novel thiophene derivatives for beta-amyloid plaque imaging, Bioorg. Med. Chem. Lett., 16, 1350, 10.1016/j.bmcl.2005.11.055 · DOI
  5. Collinge, 2007, A general model of prion strains and their pathogenicity, Science, 318, 930, 10.1126/science.1138718 · DOI · Paper page
  6. Fodero-Tavoletti, 2007, In vitro characterization of Pittsburgh compound-B binding to Lewy bodies, J. Neurosci., 27, 10365, 10.1523/JNEUROSCI.0630-07.2007 · DOI · Paper page
  7. Forsberg, A., Engler, H., Almkvist, O., Blomquist, G., Hagman, G.,Wall, A., Ringheim, A., Langstrom, B., Nordberg, A., 2007. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol. Aging, doi:10.1016/j.neurobiolaging.2007.03.029, in press. · DOI · Paper page
  8. Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
  9. Ikeda, 1989, Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody, Lab. Invest., 60, 113
  10. Kalback, 2002, APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques, Biochemistry, 41, 922, 10.1021/bi015685+ · DOI · Paper page
  11. Kayed, 2006, Conformation-dependent anti-amyloid oligomer antibodies, Methods Enzymol., 413, 326, 10.1016/S0076-6879(06)13017-7 · DOI · Paper page
  12. Kemppainen, 2007, PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment, Neurology, 68, 1603, 10.1212/01.wnl.0000260969.94695.56 · DOI · Paper page
  13. Klunk, 2004, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B, Ann. Neurol., 55, 306, 10.1002/ana.20009 · DOI · Paper page
  14. Klunk, 2004, Amyloid deposits in transgenic PS1/APP mice do not bind the amyloid PET tracer, PIB, in the same manner as human brain amyloid, Neurobiol. Aging, 25, 232, 10.1016/S0197-4580(04)80779-6 · doi:10.1016/s0197-4580(04)80779-6
  15. Klunk, 2003, The binding of 2-(4′-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component, J. Neurosci., 23, 2086, 10.1523/JNEUROSCI.23-06-02086.2003 · DOI · Paper page
  16. Kung, M.P., Hou., C., Zhuang, Z.P., Cross, A.J., Maier, D.L., Kung, H.F., 2004. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice. Eur. J. Nucl. Med. Mol. Imag. (10.1007/S00259-004-1487-z). · DOI
  17. Kung, 2002, IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques, Brain Res., 956, 202, 10.1016/S0006-8993(02)03436-4 · DOI · Paper page
  18. Kuo, 2001, Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains, J. Biol. Chem., 276, 12991, 10.1074/jbc.M007859200 · DOI · Paper page
  19. LeVine, 2003, Y10W beta(1–40) fluorescence reflects epitope exposure in conformers of Alzheimer's beta-peptide, Arch. Biochem. Biophys., 417, 112, 10.1016/S0003-9861(03)00322-9 · DOI
  20. LeVine, 2005, Multiple ligand binding sites on A beta(l–40) fibrils, Amyloid, 12, 5, 10.1080/13506120500032295 · DOI · Paper page
  21. LeVine, 2006, Chapter 11. Models of Alzheimer's disease, 121
  22. Lim, 2006, Solid-state NMR structural studies of the fibril form of a mutant mouse prion peptide PrP89-143(P101L), Solid State Nucl. Magn. Reson., 29, 183, 10.1016/j.ssnmr.2005.09.017 · doi:10.1016/j.ssnmr.2005.09.017
  23. Matsunaga, 2002, A pH-dependent conformational transition of Abeta peptide and physicochemical properties of the conformers in the glial cell, Biochem. J., 361, 547, 10.1042/bj3610547 · doi:10.1042/bj3610547
  24. Miller, 2003, Humoral immune response to fibrillar beta-amyloid peptide, Biochemistry, 42, 11682, 10.1021/bi030100s · DOI
  25. Murphy, 2007, Aβ solubility and deposition during AD progression and in APPXPS1 Knock-in mice, Neurobiol. Dis., 10.1016/j.nbd.2007.06.002 · DOI
  26. Nilsson, 2007, Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes, ACS Chem. Biol., 2, 553, 10.1021/cb700116u · DOI · Paper page
  27. O’Nuallain, 2002, Conformational antibodies recognizing a generic amyloid fibril epitope, Proc. Natl. Acad. Sci. U.S.A., 99, 1485, 10.1073/pnas.022662599 · DOI · Paper page
  28. Petkova, 2006, Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils, Biochemistry, 45, 498, 10.1021/bi051952q · DOI · Paper page
  29. Rabinovici, 2007, 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration, Neurology, 68, 1205, 10.1212/01.wnl.0000259035.98480.ed · DOI · Paper page
  30. Somerville, 1999, Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP, J. Gen. Virol., 80, 1865, 10.1099/0022-1317-80-7-1865 · DOI
  31. Tagliavini, 1988, Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals, Neurosci. Lett., 93, 191, 10.1016/0304-3940(88)90080-8 · DOI · Paper page
  32. Toyama, 2007, The structural basis of yeast prion strain variants, Nature, 449, 233, 10.1038/nature06108 · DOI · Paper page
  33. Walker, 2006, Koch's postulates and infectious proteins, Acta Neuropathol., 112, 1, 10.1007/s00401-006-0072-x · DOI
  34. Weissmann, 2004, The state of the prion, Nat. Rev. Microbiol., 2, 861, 10.1038/nrmicro1025 · DOI · Paper page
  35. Wetzel, 2007, Plasticity of amyloid fibrils, Biochemistry, 46, 1, 10.1021/bi0620959 · DOI
  36. Wisniewski, 1989, Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease, Acta Neuropathol. (Berl.), 78, 337, 10.1007/BF00688170 · DOI · Paper page
  37. Yagi, 2007, Visualization and classification of amyloid beta supramolecular assemblies, Biochemistry, 46, 15009, 10.1021/bi701842n · DOI
  38. Yamaguchi, 1988, A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining, Acta Neuropathol., 76, 541, 10.1007/BF00689591 · DOI · Paper page
  39. Ye, 2005, Delineation of PET imaging agent binding sites on beta -amyloid peptide fibrils, J. Biol. Chem., 280, 23599, 10.1074/jbc.M501285200 · DOI · Paper page
  40. Yoshiike, 2007, Pore-forming proteins share structural and functional homology with amyloid oligomers, Neuromol. Med., 9, 270, 10.1007/s12017-007-0003-6 · DOI
  41. Zhang-Nunes, 2006, The cerebral beta-amyloid angiopathies: hereditary and sporadic, Brain Pathol., 16, 30, 10.1111/j.1750-3639.2006.tb00559.x · DOI · Paper page

Cited by

See all 52

Metadata

Authors
LeVine, H., & Walker, L. C.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2010-04
Volume
31
Issue
4
Pages
542-548
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2015234786
Cited by
52
References
14
FWCI
2.01
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular polymorphism of Aβ in Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2008.05.026
The paper
LeVine, H., & Walker, L. C. (2010). Molecular polymorphism of Aβ in Alzheimer's disease. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2008.05.026

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.